415 related articles for article (PubMed ID: 24507546)
21. [Chronic inflammatory demyelinating polyradiculoneuropathy].
Franques J; Azulay JP; Pouget J; Attarian S
Rev Med Interne; 2010 Jun; 31(6):411-6. PubMed ID: 20395023
[TBL] [Abstract][Full Text] [Related]
22. Chronic inflammatory demyelinating polyradiculoneuropathy: a role for haematopoietic stem cell transplantation?
Kazmi MA; Mahdi-Rogers M; Sanvito L
Autoimmunity; 2008 Dec; 41(8):611-5. PubMed ID: 18958756
[TBL] [Abstract][Full Text] [Related]
23. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
Hughes RA; Mehndiratta MM
Cochrane Database Syst Rev; 2012 Aug; (8):CD002062. PubMed ID: 22895925
[TBL] [Abstract][Full Text] [Related]
24. Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside.
Peltier AC; Donofrio PD
Semin Neurol; 2012 Jul; 32(3):187-95. PubMed ID: 23117943
[TBL] [Abstract][Full Text] [Related]
25. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
Hughes RA; Mehndiratta MM
Cochrane Database Syst Rev; 2015 Jan; 1():CD002062. PubMed ID: 25561247
[TBL] [Abstract][Full Text] [Related]
26. Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
Dalakas MC
J Peripher Nerv Syst; 2012 May; 17 Suppl 2():34-9. PubMed ID: 22548621
[TBL] [Abstract][Full Text] [Related]
27. Current treatments for CIDP.
Ropper AH
Neurology; 2003 Apr; 60(8 Suppl 3):S16-22. PubMed ID: 12707418
[TBL] [Abstract][Full Text] [Related]
28. Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study.
RMC Trial Group
Lancet Neurol; 2009 Feb; 8(2):158-64. PubMed ID: 19136303
[TBL] [Abstract][Full Text] [Related]
29. Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): mechanisms of action and clinical and genetic considerations.
Dalakas MC; Latov N; Kuitwaard K
Expert Rev Neurother; 2022; 22(11-12):953-962. PubMed ID: 36645654
[TBL] [Abstract][Full Text] [Related]
30. Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies.
Melzer N; Meuth SG
Clin Exp Immunol; 2014 Mar; 175(3):359-72. PubMed ID: 24032475
[TBL] [Abstract][Full Text] [Related]
31. Chronic inflammatory demyelinating polyradiculoneuropathy in patients with diabetes mellitus - treatment with intravenous immunoglobulins: A systematic review.
Andrusiów S; Pawlak Z; Stańczykiewicz B; Bogunia-Kubik K; Koszewicz M
Biomed Pharmacother; 2023 Aug; 164():114974. PubMed ID: 37290187
[TBL] [Abstract][Full Text] [Related]
32. Conventional and unconventional therapies in typical and atypical chronic inflammatory demyelinating polyneuropathy with different clinical course of progression.
Hung SKY; Hiew FL; Viswanathan S; Puvanarajah S
J Peripher Nerv Syst; 2018 Sep; 23(3):183-189. PubMed ID: 30027593
[TBL] [Abstract][Full Text] [Related]
33. Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy.
Dyer WB; Tan JC; Day T; Kiers L; Kiernan MC; Yiannikas C; Reddel S; Ng K; Mondy P; Dennington PM; Dean MM; Trist HM; Dos Remedios C; Hogarth PM; Vucic S; Irving DO
Brain Behav; 2016 Oct; 6(10):e00516. PubMed ID: 27781132
[TBL] [Abstract][Full Text] [Related]
34. Chronic inflammatory demyelinating polyneuropathy as an autoimmune disease.
Rodríguez Y; Vatti N; Ramírez-Santana C; Chang C; Mancera-Páez O; Gershwin ME; Anaya JM
J Autoimmun; 2019 Aug; 102():8-37. PubMed ID: 31072742
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of hematopoietic stem cell transplantation treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis.
Zheng Y; Hu J; Sun C; Zhao C; Lin J
Eur J Neurol; 2023 Aug; 30(8):2570-2582. PubMed ID: 37170791
[TBL] [Abstract][Full Text] [Related]
36. Maintenance IV immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy.
Kuitwaard K; Fokkink WR; Brusse E; Vrancken AFJE; Eftimov F; Notermans NC; van der Kooi AJ; Merkies ISJ; Jacobs BC; van Doorn PA
J Peripher Nerv Syst; 2017 Dec; 22(4):425-432. PubMed ID: 29092099
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.
Latov N
Nat Rev Neurol; 2014 Aug; 10(8):435-46. PubMed ID: 24980070
[TBL] [Abstract][Full Text] [Related]
38. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
Brannagan TH
Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
[TBL] [Abstract][Full Text] [Related]
39. Childhood acute and chronic immune-mediated polyradiculoneuropathies.
Rabie M; Nevo Y
Eur J Paediatr Neurol; 2009 May; 13(3):209-18. PubMed ID: 18585069
[TBL] [Abstract][Full Text] [Related]
40. Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Hughes R
J Clin Immunol; 2010 May; 30 Suppl 1():S70-3. PubMed ID: 20393791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
